학술논문
Efficacy and safety of antiviral plus anti-spike monoclonal antibody combination therapy vs. monotherapy for high-risk immunocompromised patients with mild-to-moderate SARS-CoV2 infection during the Omicron era. A prospective cohort study
Document Type
Article
Author
Source
In: International Journal of Antimicrobial Agents . (International Journal of Antimicrobial Agents, March 2024, 63(3))
Subject
Language
English
ISSN
18727913
09248579
09248579